FONT-SIZE Plus   Neg

CytoDyn Appoints Nader Pourhassan As Interim CEO - Quick Facts

CytoDyn Inc. (CYDY) announced the appointment of Nader Pourhassan as its new interim Chief Executive Officer and Richard Trauger as its new Chief Scientific Officer.

Pourhassan brings over 20 years of advanced engineering and mathematics expertise as well as strong business acumen, to his new role. Prior to his new position as CEO, Pourhassan served as the Company's Managing Director of Business Development, and before that, as its Chief Operating Officer. He succeeds former President and CEO Kenneth Van Ness.

The appointment of Pourhassan to CEO follows the recent promotion of Richard Trauger from Managing Director of Science to Chief Scientific Officer on August 23, 2012.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Large U.S. companies are holding trillions of dollars overseas in an effort to avoid U.S. taxes, with big-name firms like Apple (AAPL), Pfizer (PFE) and PepsiCo (PEP) named as notable examples. This is the claim made by a pair of non-profit groups, who released a study based on the firms' financial statements. Software maker Adobe Systems Inc. (ADBE) Tuesday detailed an outlook for the full year 2016 indicated to miss Wall Street estimates, sending its shares down 8 percent in after-hours trading. Adobe expects full-year 2016 revenues of about $5.7 billion and an adjusted earnings of $2.70 per share. Analysts... Enterprise software maker Adobe (ADBE) provided updated guidance on Tuesday, predicting strong growth over the next three years by giving 2016 projections that are below what market analysts are currently expecting.
comments powered by Disqus
Follow RTT